Claudia J. Verschueren-Erpelinck

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

MDS/AML and AML with myelodysplasia-related gene mutations: clinical and molecular similarities.

MDS/AML and AML with myelodysplasia-related gene mutations: clinical and molecular similarities.

Journal: Blood advances
Published: September 11, 2025

MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemia.

MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemia.

Journal: Blood
Published: February 21, 2025

Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q.

Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q.

Journal: Blood cancer discovery
Published: October 03, 2024

Epigenetic alterations affecting hematopoietic regulatory networks as drivers of mixed myeloid/lymphoid leukemia.

Epigenetic alterations affecting hematopoietic regulatory networks as drivers of mixed myeloid/lymphoid leukemia.

Journal: Nature communications
Published: August 11, 2023

The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loops.

The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loops.

Journal: Nature communications
Published: June 10, 2021

Selective Requirement of MYB for Oncogenic Hyperactivation of a Translocated Enhancer in Leukemia.

Selective Requirement of MYB for Oncogenic Hyperactivation of a Translocated Enhancer in Leukemia.

Journal: Cancer discovery
Published: December 15, 2020

PPM1D mutations appear in complete remission after exposure to chemotherapy without predicting emerging AML relapse.

PPM1D mutations appear in complete remission after exposure to chemotherapy without predicting emerging AML relapse.

Journal: Leukemia
Published: June 22, 2020

Malignant Transformation Involving CXXC4 Mutations Identified in a Leukemic Progression Model of Severe Congenital Neutropenia.

Malignant Transformation Involving CXXC4 Mutations Identified in a Leukemic Progression Model of Severe Congenital Neutropenia.

Journal: Cell reports. Medicine
Published: April 16, 2020

Archived bone marrow smears are an excellent source for NGS-based mutation detection in acute myeloid leukemia.

Archived bone marrow smears are an excellent source for NGS-based mutation detection in acute myeloid leukemia.

Journal: Leukemia
Published: July 24, 2019

Molecular Minimal Residual Disease in Acute Myeloid Leukemia.

Molecular Minimal Residual Disease in Acute Myeloid Leukemia.

Journal: The New England journal of medicine
Published: March 31, 2018

Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia.

Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia.

Journal: Blood
Published: April 12, 2012

Acquired mutations in ASXL1 in acute myeloid leukemia: prevalence and prognostic value.

Acquired mutations in ASXL1 in acute myeloid leukemia: prevalence and prognostic value.

Journal: Haematologica
Published: November 08, 2011
Showing 1-12 of 12

Last Updated: 09/26/2026